Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts

Journal of Medicinal Chemistry

Volumn 55, Issue 11, 2012, Pages 5591-5600

  Gieling, Roben G ^a   Babur, Muhammad ^a   Mamnani, Lupti ^a   Burrows, Natalie ^a   Telfer, Brian A ^a   Carta, Fabrizio ^b   Winum, Jean Yves ^c   Scozzafava, Andrea ^b   Supuran, Claudiu T ^b   Williams, Kaye J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF FLORENCE   (Italy)

^c INSTITUT CHARLES GERHARDT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 [3' (3',5' DIMETHYLPHENYL) UREIDO]PHENYL SULFAMATE; 4 [3' (4' CHLOROPHENYL)UREIDO]PHENYL SULFAMATE; 4 [3' (4' DIMETHYLAMINO)PHENYL]UREIDO]PHENYL SULFAMATE; 4 [3' (4' METHOXYPHENYL)UREIDO]PHENYL SULFAMATE; 4 [3' (4' NITROPHENYL)UREIDO]PHENYL SULFAMATE; 4 [3' (4' PHENOXYPHENYL)UREIDO]PHENYL SULFAMATE; 4 [3' (PERFLUOROPHENYL)UREIDO]PHENYL SULFAMATE; ANTIMETASTATIC AGENT; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IX; CARBONATE DEHYDRATASE IX INHIBITOR; CARBONATE DEHYDRATASE XII; CARBONATE DEHYDRATASE XII INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANOXIA; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CELL ASSAY; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS INHIBITION; MOUSE; NONHUMAN; TREATMENT DURATION; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HUMANS; LUNG NEOPLASMS; MICE; NEOPLASM TRANSPLANTATION; PHENYLUREA COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES; TRANSPLANTATION, HETEROLOGOUS;

EID: 84862290784     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm300529u     Document Type: Article

References (32)

1. Pastorekova, S.; Parkkila, S.; Pastorek, J.; Supuran, C. T. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects J. Enzyme Inhib. Med. Chem. 2004, 19 (3) 199-229
2. Chia, S. K.; Wykoff, C. C.; Watson, P. H.; Han, C.; Leek, R. D.; Pastorek, J.; Gatter, K. C.; Ratcliffe, P.; Harris, A. L. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma J. Clin. Oncol. 2001, 19 (16) 3660-3668
3. Hussain, S. A.; Ganesan, R.; Reynolds, G.; Gross, L.; Stevens, A.; Pastorek, J.; Murray, P. G.; Perunovic, B.; Anwar, M. S.; Billingham, L.; James, N. D.; Spooner, D.; Poole, C. J.; Rea, D. W.; Palmer, D. H. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer Br. J. Cancer 2007, 96 (1) 104-109
4. Wykoff, C. C.; Beasley, N. J.; Watson, P. H.; Turner, K. J.; Pastorek, J.; Sibtain, A.; Wilson, G. D.; Turley, H.; Talks, K. L.; Maxwell, P. H.; Pugh, C. W.; Ratcliffe, P. J.; Harris, A. L. Hypoxia-inducible expression of tumor-associated carbonic anhydrases Cancer Res. 2000, 60 (24) 7075-7083
5. Brahimi-Horn, M. C.; Chiche, J.; Pouyssegur, J. Hypoxia and cancer J. Mol. Med. (Berlin) 2007, 85 (12) 1301-1307
6. Thiry, A.; Dogne, J. M.; Masereel, B.; Supuran, C. T. Targeting tumor-associated carbonic anhydrase IX in cancer therapy Trends Pharmacol. Sci. 2006, 27 (11) 566-573
7. Supuran, C. T. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators Nat. Rev. Drug Discovery 2008, 7 (2) 168-181
8. Robertson, N.; Potter, C.; Harris, A. L. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion Cancer Res. 2004, 64 (17) 6160-6165
9. Neri, D.; Supuran, C. T. Interfering with pH regulation in tumours as a therapeutic strategy Nat. Rev. Drug Discovery 2011, 10 (10) 767-777
10. Chiche, J.; Ilc, K.; Laferriere, J.; Trottier, E.; Dayan, F.; Mazure, N. M.; Brahimi-Horn, M. C.; Pouyssegur, J. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH Cancer Res. 2009, 69 (1) 358-368
11. Li, Y.; Tu, C.; Wang, H.; Silverman, D. N.; Frost, S. C. Catalysis and pH control by membrane-associated carbonic anhydrase IX in MDA-MB-231 breast cancer cells J. Biol. Chem. 2011, 286 (18) 15789-15796
12. Raghunand, N.; He, X.; van Sluis, R.; Mahoney, B.; Baggett, B.; Taylor, C. W.; Paine-Murrieta, G.; Roe, D.; Bhujwalla, Z. M.; Gillies, R. J. Enhancement of chemotherapy by manipulation of tumour pH Br. J. Cancer 1999, 80 (7) 1005-1011
13. Lou, Y.; McDonald, P. C.; Oloumi, A.; Chia, S.; Ostlund, C.; Ahmadi, A.; Kyle, A.; Auf dem Keller, U.; Leung, S.; Huntsman, D.; Clarke, B.; Sutherland, B. W.; Waterhouse, D.; Bally, M.; Roskelley, C.; Overall, C. M.; Minchinton, A.; Pacchiano, F.; Carta, F.; Scozzafava, A.; Touisni, N.; Winum, J. Y.; Supuran, C. T.; Dedhar, S. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors Cancer Res. 2011, 71 (9) 3364-3376
14. Pacchiano, F.; Carta, F.; McDonald, P. C.; Lou, Y.; Vullo, D.; Scozzafava, A.; Dedhar, S.; Supuran, C. T. Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis J. Med. Chem. 2011, 54 (6) 1896-1902
15. Winum, J. Y.; Vullo, D.; Casini, A.; Montero, J. L.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: inhibition of transmembrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates J. Med. Chem. 2003, 46 (25) 5471-5477
16. Winum, J. Y.; Vullo, D.; Casini, A.; Montero, J. L.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors J. Med. Chem. 2003, 46 (11) 2197-2204
17. Pacchiano, F.; Aggarwal, M.; Avvaru, B. S.; Robbins, A. H.; Scozzafava, A.; McKenna, R.; Supuran, C. T. Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency Chem. Commun. (Cambridge, U. K.) 2010, 46 (44) 8371-8373
18. Svastova, E.; Witarski, W.; Csaderova, L.; Kosik, I.; Skvarkova, L.; Hulikova, A.; Zatovicova, M.; Barathova, M.; Kopacek, J.; Pastorek, J.; Pastorekova, S. Carbonic anhydrase IX interacts with bicarbonate transporters in lamellipodia and increases cell migration via its catalytic domain J. Biol. Chem. 2012, 287 (5) 3392-3402
19. Ditte, P.; Dequiedt, F.; Svastova, E.; Hulikova, A.; Ohradanova-Repic, A.; Zatovicova, M.; Csaderova, L.; Kopacek, J.; Supuran, C. T.; Pastorekova, S.; Pastorek, J. Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors Cancer Res. 2011, 71 (24) 7558-7567
20. Burrows, N.; Resch, J.; Cowen, R. L.; von Wasielewski, R.; Hoang-Vu, C.; West, C. M.; Williams, K. J.; Brabant, G. Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas Endocr.-Relat. Cancer 2010, 17 (1) 61-72
21. Morgan, P. E.; Pastorekova, S.; Stuart-Tilley, A. K.; Alper, S. L.; Casey, J. R. Interactions of transmembrane carbonic anhydrase, CAIX, with bicarbonate transporters Am. J. Physiol.: Cell Physiol. 2007, 293 (2) C738-748
22. Svastova, E.; Zilka, N.; Zat'ovicova, M.; Gibadulinova, A.; Ciampor, F.; Pastorek, J.; Pastorekova, S. Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin Exp. Cell Res. 2003, 290 (2) 332-345
23. Santel, A.; Aleku, M.; Roder, N.; Mopert, K.; Durieux, B.; Janke, O.; Keil, O.; Endruschat, J.; Dames, S.; Lange, C.; Eisermann, M.; Loffler, K.; Fechtner, M.; Fisch, G.; Vank, C.; Schaeper, U.; Giese, K.; Kaufmann, J. Atu027 prevents pulmonary metastasis in experimental and spontaneous mouse metastasis models Clin. Cancer Res. 2010, 16 (22) 5469-5480
24. Okada, M.; Iwashita, S.; Koizumi, N. Efficient general method for sulfamoylation of a hydroxyl group Tetrahedron Lett. 2000, 41, 7047-7051
25. Dubois, L.; Peeters, S.; Lieuwes, N. G.; Geusens, N.; Thiry, A.; Wigfield, S.; Carta, F.; McIntyre, A.; Scozzafava, A.; Dogne, J. M.; Supuran, C. T.; Harris, A. L.; Masereel, B.; Lambin, P. Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation Radiother. Oncol. 2011, 99 (3) 424-431
26. Khalifah, R. G. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C J. Biol. Chem. 1971, 246 (8) 2561-2573
27. Scozzafava, A.; Briganti, F.; Ilies, M. A.; Supuran, C. T. Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes J. Med. Chem. 2000, 43 (2) 292-300
28. Alterio, V.; Hilvo, M.; Di Fiore, A.; Supuran, C. T.; Pan, P.; Parkkila, S.; Scaloni, A.; Pastorek, J.; Pastorekova, S.; Pedone, C.; Scozzafava, A.; Monti, S. M.; De Simone, G. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (38) 16233-16238
29. Hobbs, S.; Jitrapakdee, S.; Wallace, J. C. Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1alpha promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins Biochem. Biophys. Res. Commun. 1998, 252 (2) 368-372
30. Roberts, D. L.; Williams, K. J.; Cowen, R. L.; Barathova, M.; Eustace, A. J.; Brittain-Dissont, S.; Tilby, M. J.; Pearson, D. G.; Ottley, C. J.; Stratford, I. J.; Dive, C. Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells Br. J. Cancer 2009, 101 (8) 1290-1297
31. Burrows, N.; Babur, M.; Resch, J.; Ridsdale, S.; Mejin, M.; Rowling, E. J.; Brabant, G.; Williams, K. J. GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-1alpha (HIF-1alpha) pathways J. Clin. Endocrinol. Metab. 2011, 96 (12) E1934-E1943
32. Cowen, R. L.; Williams, K. J.; Chinje, E. C.; Jaffar, M.; Sheppard, F. C.; Telfer, B. A.; Wind, N. S.; Stratford, I. J. Hypoxia targeted gene therapy to increase the efficacy of tirapazamine as an adjuvant to radiotherapy: reversing tumor radioresistance and effecting cure Cancer Res. 2004, 64 (4) 1396-1402